{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:12:01Z","timestamp":1792239121725,"version":"4.4.0"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20243001"],"award-info":[{"award-number":["BK20243001"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130106"],"award-info":[{"award-number":["82130106"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The concept of bacterial therapy dates back over a century to clinical observations that incidental infections could induce tumor regression. Recent advances in genetic engineering and synthetic biology have since transformed bacteria into versatile living therapeutics with significant preclinical potential against diseases such as cancer, inflammatory disorders, and metabolic conditions. However, clinical translation faces considerable hurdles. Here, we provide a clinically oriented perspective on the translational gap in bacterial therapy. Drawing inspiration from the success of antibody-drug conjugates in achieving precise payload delivery, we highlight an emerging paradigm of \u201cprecision living therapeutics\u201d enabled by bacterial surface engineering. we propose the concept of \u201cTumor accessibility\u201d for the first time, and identify its insufficiency as a critical bottleneck in current therapeutic applications. We then systematically summarize recent advances in bacterial surface engineering, encompassing physical, chemical, and biological strategies, with a focus on their capacity to evade immune clearance, enhance tumor colonization, and improve therapeutic performance. Chemical approaches primarily involve covalent conjugation, including the SpyTag\/SpyCatcher system and bioorthogonal click chemistry-based metabolic labeling. Physical strategies center on cell membrane encapsulation and surface coatings such as layer-by-layer encapsulation. Biological strategies include cell camouflage and genetic modulation of surface structures, display of functional biomolecules, and affinity-based systems such as biotin-streptavidin interactions. Finally, we discuss integrative strategies that combine surface-engineered bacteria with conventional treatment modalities, including physical therapy, chemotherapy, and immunotherapy. We propose that future clinical translation of bacterial therapy should shift from localized modification design to a holistic consideration of systemic accessibility.<\/jats:p>","DOI":"10.1186\/s13045-026-01827-1","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T08:07:05Z","timestamp":1783411625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["From tumor targeting to tumor accessibility: surface-engineered bacteria as precision living therapeutics for translational medicine"],"prefix":"10.1186","volume":"19","author":[{"given":"Liyuan","family":"Qiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengxuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zichun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"1827_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41568-025-00869-w","volume":"25","author":"A Zippelius","year":"2025","unstructured":"Zippelius A, Tolaney SM, Tarantino P, Balthasar JP, Thurber GM. Unveiling the molecular and immunological drivers of antibody\u2013drug conjugates in cancer treatment. Nat Rev Cancer. 2025;25:925\u201344.","journal-title":"Nat Rev Cancer"},{"key":"1827_CR2","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41571-023-00850-2","volume":"21","author":"K Tsuchikama","year":"2024","unstructured":"Tsuchikama K, Anami Y, Ha SYY, Yamazaki CM. Exploring the next generation of antibody\u2013drug conjugates. Nat Rev Clin Oncol. 2024;21:203\u201323.","journal-title":"Nat Rev Clin Oncol"},{"key":"1827_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41571-025-01075-1","volume":"22","author":"J Li","year":"2025","unstructured":"Li J, Liu C, Zhang P, Shen L, Qi C. Optimizing CAR T cell therapy for solid tumours: a clinical perspective. Nat Rev Clin Oncol. 2025;22:953\u201368.","journal-title":"Nat Rev Clin Oncol"},{"key":"1827_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.102353","volume":"6","author":"G Escobar","year":"2025","unstructured":"Escobar G, Berger TR, Maus MV. CAR-T cells in solid tumors: challenges and breakthroughs. Cell Rep Med. 2025;6:102353.","journal-title":"Cell Rep Med"},{"key":"1827_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF. Drug penetration in solid tumours. Nat Rev Cancer. 2006;6:583\u201392.","journal-title":"Nat Rev Cancer"},{"key":"1827_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrc.2017.93","volume":"17","author":"MW Dewhirst","year":"2017","unstructured":"Dewhirst MW, Secomb TW. Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer. 2017;17:738\u201350.","journal-title":"Nat Rev Cancer"},{"key":"1827_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2026.105434","author":"Z Guo","year":"2026","unstructured":"Guo Z, et al. Challenges and recent advances in CAR-T cell therapy for solid tumors. Crit Rev Oncol Hematol. 2026. https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105434.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1827_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41577-024-01111-8","volume":"25","author":"M Roerden","year":"2025","unstructured":"Roerden M, Spranger S. Cancer immune evasion, immunoediting and intratumour heterogeneity. Nat Rev Immunol. 2025;25:353\u201369.","journal-title":"Nat Rev Immunol"},{"key":"1827_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113863","volume":"28","author":"C Han","year":"2025","unstructured":"Han C, et al. A stable and antibiotic-free plasmid expression system for Salmonella typhimurium VNP20009 in tumor therapy. iScience. 2025;28:113863.","journal-title":"iScience"},{"key":"1827_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","volume":"21","author":"S-Y Kwon","year":"2024","unstructured":"Kwon S-Y, Thi-Thu Ngo H, Son J, Hong Y, Min J-J. Exploiting bacteria for cancer immunotherapy. Nat Rev Clin Oncol. 2024;21:569\u201389.","journal-title":"Nat Rev Clin Oncol"},{"key":"1827_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202406140","volume":"36","author":"L Wu","year":"2024","unstructured":"Wu L, et al. Dual-engineered macrophage-microbe encapsulation for metastasis immunotherapy. Adv Mater. 2024;36:e2406140.","journal-title":"Adv Mater"},{"key":"1827_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54883-x","volume":"15","author":"Y Wu","year":"2024","unstructured":"Wu Y, et al. Thermal-responsive activation of engineered bacteria to trigger antitumor immunity post microwave ablation therapy. Nat Commun. 2024;15:10503.","journal-title":"Nat Commun"},{"issue":"1","key":"1827_CR13","doi-asserted-by":"publisher","first-page":"6116","DOI":"10.1038\/s41467-021-26367-9","volume":"12","author":"V Raman","year":"2021","unstructured":"Raman V, et al. Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases. Nat Commun. 2021;12:6116.","journal-title":"Nat Commun"},{"key":"1827_CR14","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41420-025-02897-9","volume":"12","author":"KV Nguyen","year":"2026","unstructured":"Nguyen KV, et al. Salmonella typhimurium co-expressing cytolysin A and hyaluronidase suppresses tumor growth and metastasis. Cell Death Discovery. 2026;12:75.","journal-title":"Cell Death Discovery"},{"key":"1827_CR15","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1038\/s41388-026-03796-8","volume":"45","author":"S Hong","year":"2026","unstructured":"Hong S, et al. Antitumor immunotoxin expression is enhanced by Escherichia coli csrB-promoter activity. Oncogene. 2026;45:2046\u201357.","journal-title":"Oncogene"},{"key":"1827_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4161\/bbug.1.6.13146","volume":"1","author":"CK Baban","year":"2010","unstructured":"Baban CK, Cronin M, O\u2019Hanlon D, O\u2019Sullivan GC, Tangney M. Bacteria as vectors for gene therapy of cancer. Bioeng Bugs. 2010;1:385\u201394.","journal-title":"Bioeng Bugs"},{"key":"1827_CR17","doi-asserted-by":"publisher","first-page":"112892","DOI":"10.1016\/j.intimp.2024.112892","volume":"141","author":"P Chen","year":"2024","unstructured":"Chen P, et al. Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model. Int Immunopharmacol. 2024;141:112892.","journal-title":"Int Immunopharmacol"},{"key":"1827_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nbt.4222","volume":"36","author":"VM Isabella","year":"2018","unstructured":"Isabella VM, et al. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nat Biotechnol. 2018;36:857\u201364.","journal-title":"Nat Biotechnol"},{"key":"1827_CR19","doi-asserted-by":"publisher","first-page":"2447814","DOI":"10.1080\/19490976.2024.2447814","volume":"17","author":"D Zhou","year":"2025","unstructured":"Zhou D, et al. Hypoglycemic effect of C. butyricum-pMTL007-GLP-1 engineered probiotics on type 2 diabetes mellitus. Gut Microbes. 2025;17:2447814.","journal-title":"Gut Microbes"},{"key":"1827_CR20","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","volume":"57","author":"P Gontero","year":"2010","unstructured":"Gontero P, et al. The Role of Bacillus Calmette-Gu\u00e9rin in the Treatment of Non\u2013Muscle-Invasive Bladder Cancer. Eur Urol. 2010;57:410\u201329.","journal-title":"Eur Urol"},{"key":"1827_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrurol.2014.15","volume":"11","author":"G Redelman-Sidi","year":"2014","unstructured":"Redelman-Sidi G, Glickman MS, Bochner BH. The mechanism of action of BCG therapy for bladder cancer\u2013a current perspective. Nat Rev Urol. 2014;11:153\u201362.","journal-title":"Nat Rev Urol"},{"key":"1827_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0168-3659(01)00340-6","volume":"74","author":"J Tjuvajev","year":"2001","unstructured":"Tjuvajev J, et al. Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET\u2122) for diagnostic imaging. J Controlled Release. 2001;74:313\u20135.","journal-title":"J Controlled Release"},{"key":"1827_CR23","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1086\/315497","volume":"181","author":"C Clairmont","year":"2000","unstructured":"Clairmont C, et al. Biodistribution and Genetic Stability of the Novel Antitumor Agent VNP20009, a Genetically Modified Strain of Salmonella typhimuvium. J Infect Dis. 2000;181:1996\u20132002.","journal-title":"J Infect Dis"},{"key":"1827_CR24","doi-asserted-by":"publisher","first-page":"e2404069","DOI":"10.1002\/advs.202404069","volume":"11","author":"L Wu","year":"2024","unstructured":"Wu L, et al. Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity. Adv Sci (Weinh). 2024;11:e2404069.","journal-title":"Adv Sci (Weinh)"},{"key":"1827_CR25","doi-asserted-by":"publisher","first-page":"15172","DOI":"10.1073\/pnas.0406242101","volume":"101","author":"N Agrawal","year":"2004","unstructured":"Agrawal N, et al. Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A. 2004;101:15172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1827_CR26","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1158\/1078-0432.CCR-04-2510","volume":"11","author":"DH Thamm","year":"2005","unstructured":"Thamm DH, et al. Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation. Clin Cancer Res. 2005;11:4827\u201334.","journal-title":"Clin Cancer Res"},{"key":"1827_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s12276-024-01191-5","volume":"56","author":"S Mun","year":"2024","unstructured":"Mun S, Lee HJ, Kim P. Rebuilding the microenvironment of primary tumors in humans: a focus on stroma. Exp Mol Med. 2024;56:527\u201348.","journal-title":"Exp Mol Med"},{"key":"1827_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","volume":"20","author":"JF Toso","year":"2002","unstructured":"Toso JF, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol. 2002;20:142\u201352.","journal-title":"J Clin Oncol"},{"key":"1827_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/00002371-200303000-00011","volume":"26","author":"DM Heimann","year":"2003","unstructured":"Heimann DM, Rosenberg SA. Continuous intravenous administration of live genetically modified Salmonella typhimurium in patients with metastatic melanoma. J Immunother. 2003;26:179\u201380.","journal-title":"J Immunother"},{"key":"1827_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2012.00345","author":"S Kaese","year":"2012","unstructured":"Kaese S, Verheule S. Cardiac electrophysiology in mice: a matter of size. Front Physiol. 2012. https:\/\/doi.org\/10.3389\/fphys.2012.00345.","journal-title":"Front Physiol"},{"key":"1827_CR31","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.ajpath.2021.07.009","volume":"191","author":"A Pandita","year":"2021","unstructured":"Pandita A, et al. Intussusceptive angiogenesis in human metastatic malignant melanoma. Am J Pathol. 2021;191:2023\u201338.","journal-title":"Am J Pathol"},{"key":"1827_CR32","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1161\/STROKEAHA.114.005639","volume":"45","author":"FR Sharp","year":"2014","unstructured":"Sharp FR, Jickling GC. Modeling Immunity and Inflammation in Stroke. Stroke. 2014;45:e179\u201380.","journal-title":"Stroke"},{"key":"1827_CR33","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.4049\/jimmunol.1000284","volume":"186","author":"MK Siggins","year":"2011","unstructured":"Siggins MK, et al. Absent Bactericidal Activity of Mouse Serum against Invasive African Nontyphoidal Salmonella Results from Impaired Complement Function but Not a Lack of Antibody. J Immunol. 2011;186:2365\u201371.","journal-title":"J Immunol"},{"key":"1827_CR34","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1097\/SHK.0000000000001302","volume":"52","author":"T Lin","year":"2019","unstructured":"Lin T, et al. Different Bactericidal and Inflammatory Activities of Human and Mouse Blood. Shock. 2019;52:e85\u201391.","journal-title":"Shock"},{"key":"1827_CR35","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","volume":"344","author":"MJ Walport","year":"2001","unstructured":"Walport MJ, Complement. First of two parts. N Engl J Med. 2001;344:1058\u201366.","journal-title":"N Engl J Med"},{"key":"1827_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03705-y","volume":"9","author":"D Rosenblum","year":"2018","unstructured":"Rosenblum D, Joshi N, Tao W, Karp JM, Peer D. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9:1410.","journal-title":"Nat Commun"},{"key":"1827_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01536-y","volume":"8","author":"D Fan","year":"2023","unstructured":"Fan D, et al. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8:293.","journal-title":"Signal Transduct Target Ther"},{"key":"1827_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/s41590-026-02527-1","volume":"27","author":"Mapping where mouse","year":"2026","unstructured":"Mapping where mouse. models match \u2014 and miss \u2014 human tumor immunity. Nat Immunol. 2026;27:1100\u20131.","journal-title":"Nat Immunol"},{"key":"1827_CR39","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/s41590-026-02505-7","volume":"27","author":"T Courau","year":"2026","unstructured":"Courau T, et al. Differential assembly of mouse and human tumor microenvironments. Nat Immunol. 2026;27:1282\u201393.","journal-title":"Nat Immunol"},{"key":"1827_CR40","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/sj.cgt.7700634","volume":"10","author":"J Nemunaitis","year":"2003","unstructured":"Nemunaitis J, et al. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther. 2003;10:737\u201344.","journal-title":"Cancer Gene Ther"},{"key":"1827_CR41","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1093\/annonc\/mdy423","volume":"29","author":"A Marabelle","year":"2018","unstructured":"Marabelle A, et al. Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT). Ann Oncol. 2018;29:2163\u201374.","journal-title":"Ann Oncol"},{"key":"1827_CR42","doi-asserted-by":"crossref","unstructured":"Garcia Castillo J, et al. Cellular mechanisms underlying beneficial versus detrimental effects of bacterial antitumor immunotherapy. Immunity. 2025;58(8):2002\u20132018.e2005.","DOI":"10.1016\/j.immuni.2025.05.001"},{"key":"1827_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138225","volume":"285","author":"M Luo","year":"2025","unstructured":"Luo M, et al. Preparation and characterization of microcapsules and tablets for probiotic encapsulation via whey protein isolate-nanochitin complex coacervation. Int J Biol Macromol. 2025;285:138225.","journal-title":"Int J Biol Macromol"},{"key":"1827_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146358","volume":"321","author":"KF Calumba","year":"2025","unstructured":"Calumba KF, Zhong Q. Shellac-based microgels for enhanced delivery of Lactobacillus bulgaricus ATCC 11842. Int J Biol Macromol. 2025;321:146358.","journal-title":"Int J Biol Macromol"},{"key":"1827_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/nu9091021","author":"P Markowiak","year":"2017","unstructured":"Markowiak P, \u015ali\u017cewska K. Effects of probiotics, prebiotics, and synbiotics on human health. Nutrients. 2017. https:\/\/doi.org\/10.3390\/nu9091021.","journal-title":"Nutrients"},{"key":"1827_CR46","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2197837","volume":"15","author":"H Lai","year":"2023","unstructured":"Lai H, et al. Effects of dietary fibers or probiotics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut Microbes. 2023;15:2197837.","journal-title":"Gut Microbes"},{"key":"1827_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1039\/c3fo60348b","volume":"5","author":"SM Finegold","year":"2014","unstructured":"Finegold SM, et al. Xylooligosaccharide increases bifidobacteria but not lactobacilli in human gut microbiota. Food Funct. 2014;5:436\u201345.","journal-title":"Food Funct"},{"key":"1827_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-30909-0","volume":"13","author":"LM Schmitt","year":"2023","unstructured":"Schmitt LM, et al. Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder. Sci Rep. 2023;13:5192.","journal-title":"Sci Rep"},{"key":"1827_CR49","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s00535-016-1224-y","volume":"52","author":"K Han","year":"2017","unstructured":"Han K, Wang J, Seo J-G, Kim H. Efficacy of double-coated probiotics for irritable bowel syndrome: a randomized double-blind controlled trial. J Gastroenterol. 2017;52:432\u201343.","journal-title":"J Gastroenterol"},{"key":"1827_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-025-01766-3","volume":"19","author":"Y Wang","year":"2025","unstructured":"Wang Y, Xiao S, Yu W, Han B, Guo G. Engineering bacteria for enhanced tumor therapy: from surface modification to synthetic genetic circuits. J Hematol Oncol. 2025;19:7.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"1827_CR51","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1038\/s41467-019-11390-8","volume":"10","author":"Z Cao","year":"2019","unstructured":"Cao Z, Cheng S, Wang X, Pang Y, Liu J. Camouflaging bacteria by wrapping with cell membranes. Nat Commun. 2019;10:3452.","journal-title":"Nat Commun"},{"key":"1827_CR52","doi-asserted-by":"publisher","first-page":"10980","DOI":"10.1073\/pnas.1106634108","volume":"108","author":"CM Hu","year":"2011","unstructured":"Hu CM, et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci U S A. 2011;108:10980\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1827_CR53","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.bcmd.2010.02.016","volume":"45","author":"RK Tsai","year":"2010","unstructured":"Tsai RK, Rodriguez PL, Discher DE. Self inhibition of phagocytosis: the affinity of \u2018marker of self\u2019 CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. Blood Cells Molecules Dis. 2010;45:67\u201374.","journal-title":"Blood Cells Molecules Dis"},{"key":"1827_CR54","doi-asserted-by":"crossref","unstructured":"Lin S et al. Mucosal immunity\u2013mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer\u2019s patches. Sci Adv. 2021;7(20):eabf0677.","DOI":"10.1126\/sciadv.abf0677"},{"key":"1827_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102043","volume":"33","author":"R Jiang","year":"2025","unstructured":"Jiang R, et al. Sonogenetics regulation of intelligent engineered bacteria to reverse immune escape. Mater Today Bio. 2025;33:102043.","journal-title":"Mater Today Bio"},{"key":"1827_CR56","doi-asserted-by":"publisher","first-page":"34219","DOI":"10.1021\/acsnano.4c11658","volume":"18","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. Targeted Initiation of Trained Immunity in Tumor-Associated Macrophages with Membrane-Camouflaged Bacillus Calmette-Gu\u00e9rin for Lung Carcinoma Immunotherapy. ACS Nano. 2024;18:34219\u201334.","journal-title":"ACS Nano"},{"key":"1827_CR57","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends Cancer. 2019;5:822\u201334.","journal-title":"Trends Cancer"},{"key":"1827_CR58","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","volume":"44","author":"I Nasir","year":"2023","unstructured":"Nasir I, et al. Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. Trends Immunol. 2023;44:971\u201385.","journal-title":"Trends Immunol"},{"key":"1827_CR59","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.ccell.2024.04.011","volume":"42","author":"MJ van Elsas","year":"2024","unstructured":"van Elsas MJ, et al. Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy. Cancer Cell. 2024;42:1032-1050.e1010.","journal-title":"Cancer Cell"},{"key":"1827_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther. 2025;10:268.","journal-title":"Signal Transduct Target Ther"},{"key":"1827_CR61","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.chom.2023.09.006","volume":"31","author":"V Raman","year":"2023","unstructured":"Raman V, et al. Build-a-bug workshop: Using microbial-host interactions and synthetic biology tools to create cancer therapies. Cell Host Microbe. 2023;31:1574\u201392.","journal-title":"Cell Host Microbe"},{"key":"1827_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114443","author":"F Wu","year":"2022","unstructured":"Wu F, Liu J. Decorated bacteria and the application in drug delivery. Adv Drug Deliv Rev. 2022. https:\/\/doi.org\/10.1016\/j.addr.2022.114443.","journal-title":"Adv Drug Deliv Rev"},{"key":"1827_CR63","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1039\/D1CC06138K","volume":"58","author":"Y Kong","year":"2022","unstructured":"Kong Y, Du Q, Li J, Xing H. Engineering bacterial surface interactions using DNA as a programmable material. Chem Commun. 2022;58:3086\u2013100.","journal-title":"Chem Commun"},{"key":"1827_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002406","author":"P Feng","year":"2020","unstructured":"Feng P, Cao Z, Wang X, Li J, Liu J. On-demand bacterial reactivation by restraining within a triggerable nanocoating. Adv Mater. 2020. https:\/\/doi.org\/10.1002\/adma.202002406.","journal-title":"Adv Mater"},{"issue":"11","key":"1827_CR65","doi-asserted-by":"publisher","first-page":"eade0997","DOI":"10.1126\/sciadv.ade0997","volume":"9","author":"Z Geng","year":"2023","unstructured":"Geng Z, Wang X, Wu F, Cao Z, Liu J. Biointerface mineralization generates ultraresistant gut microbes as oral biotherapeutics. Sci Adv. 2023;9:eade0997.","journal-title":"Sci Adv"},{"key":"1827_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29672-z","author":"J Pan","year":"2022","unstructured":"Pan J, et al. A single-cell nanocoating of probiotics for enhanced amelioration of antibiotic-associated diarrhea. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-29672-z.","journal-title":"Nat Commun"},{"key":"1827_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13727-9","author":"Z Cao","year":"2019","unstructured":"Cao Z, Wang X, Pang Y, Cheng S, Liu J. Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment. Nat Commun. 2019. https:\/\/doi.org\/10.1038\/s41467-019-13727-9.","journal-title":"Nat Commun"},{"key":"1827_CR68","doi-asserted-by":"publisher","first-page":"9486","DOI":"10.1002\/adma.201603270","volume":"28","author":"AC Anselmo","year":"2016","unstructured":"Anselmo AC, McHugh KJ, Webster J, Langer R, Jaklenec A. Layer-by-Layer Encapsulation of Probiotics for Delivery to the Microbiome. Adv Mater. 2016;28:9486\u201390.","journal-title":"Adv Mater"},{"key":"1827_CR69","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.2174\/1381612821666150115144003","volume":"21","author":"J Che","year":"2015","unstructured":"Che J, Okeke CI, Hu ZB, Xu J. DSPE-PEG: a distinctive component in drug delivery system. Curr Pharm Des. 2015;21:1598\u2013605.","journal-title":"Curr Pharm Des"},{"key":"1827_CR70","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1039\/D3CS00369H","volume":"52","author":"S Lin","year":"2023","unstructured":"Lin S, et al. Surface-modified bacteria: synthesis, functionalization and biomedical applications. Chem Soc Rev. 2023;52:6617\u201343.","journal-title":"Chem Soc Rev"},{"key":"1827_CR71","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.GPP3-0044-2018","author":"M Rohde","year":"2019","unstructured":"Rohde M. The Gram-positive bacterial cell wall. Microbiol Spectr. 2019. https:\/\/doi.org\/10.1128\/microbiolspec.GPP3-0044-2018.","journal-title":"Microbiol Spectr"},{"key":"1827_CR72","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1021\/acs.accounts.5c00271","volume":"58","author":"M Chen","year":"2025","unstructured":"Chen M, Liu J. Regulating Bacteria\u2013Host Interactions for Disease Intervention by Covalent Conjugation of Bacterial Surface. Acc Chem Res. 2025;58:2110\u201323.","journal-title":"Acc Chem Res"},{"key":"1827_CR73","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1038\/nprot.2013.102","volume":"8","author":"CS Theile","year":"2013","unstructured":"Theile CS, et al. Site-specific N-terminal labeling of proteins using sortase-mediated reactions. Nat Protoc. 2013;8:1800\u20137.","journal-title":"Nat Protoc"},{"key":"1827_CR74","doi-asserted-by":"crossref","unstructured":"Zhao S et al. Live bacterial chemistry in biomedicine. Chem. 2025;11(4):102545.","DOI":"10.1016\/j.chempr.2025.102545"},{"key":"1827_CR75","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/s41563-022-01360-9","volume":"21","author":"F Zhang","year":"2022","unstructured":"Zhang F, et al. Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia. Nat Mater. 2022;21:1324\u201332.","journal-title":"Nat Mater"},{"key":"1827_CR76","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004529","author":"DW Zheng","year":"2020","unstructured":"Zheng DW, et al. Prebiotics-encapsulated probiotic spores regulate gut microbiota and suppress colon cancer. Adv Mater. 2020. https:\/\/doi.org\/10.1002\/adma.202004529.","journal-title":"Adv Mater"},{"key":"1827_CR77","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jconrel.2024.08.036","volume":"374","author":"P Peng","year":"2024","unstructured":"Peng P, et al. Bioorthogonal conjugation and responsive nanocoating of probiotics for inflammatory bowel disease. J Controlled Release. 2024;374:538\u201349.","journal-title":"J Controlled Release"},{"key":"1827_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-023-02830-z","author":"Z He","year":"2023","unstructured":"He Z, et al. BSA modification of bacterial surface: a promising anti-cancer therapeutic strategy. BMC Microbiol. 2023. https:\/\/doi.org\/10.1186\/s12866-023-02830-z.","journal-title":"BMC Microbiol"},{"key":"1827_CR79","doi-asserted-by":"crossref","unstructured":"Vargason AM, Santhosh S, Anselmo AC. Surface Modifications for Improved Delivery and Function of Therapeutic Bacteria. Small. 2020;16(25):e2001705.","DOI":"10.1002\/smll.202001705"},{"key":"1827_CR80","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ijbiomac.2022.08.179","volume":"221","author":"A Mushtaq","year":"2022","unstructured":"Mushtaq A, Li L, A A, Gr\u00f8ndahl L. Characterisation of products from EDC-mediated PEG substitution of chitosan allows optimisation of reaction conditions. Int J Biol Macromol. 2022;221:204\u201311.","journal-title":"Int J Biol Macromol"},{"key":"1827_CR81","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26956-8","author":"Z Geng","year":"2021","unstructured":"Geng Z, et al. Aptamer-assisted tumor localization of bacteria for enhanced biotherapy. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-26956-8.","journal-title":"Nat Commun"},{"key":"1827_CR82","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-025-08629-4","volume":"640","author":"J Lesbats","year":"2025","unstructured":"Lesbats J, et al. Macrophages recycle phagocytosed bacteria to fuel immunometabolic responses. Nature. 2025;640:524\u201333.","journal-title":"Nature"},{"key":"1827_CR83","doi-asserted-by":"publisher","first-page":"10297","DOI":"10.1021\/ja00052a028","volume":"114","author":"TL Amyes","year":"1992","unstructured":"Amyes TL, Richard JP. Generation and stability of a simple thiol ester enolate in aqueous solution. J Am Chem Soc. 1992;114:10297\u2013302.","journal-title":"J Am Chem Soc"},{"key":"1827_CR84","doi-asserted-by":"crossref","unstructured":"Chen M, et al. Upconversion dual-photosensitizer\u2013expressing bacteria for near-infrared monochromatically excitable synergistic phototherapy. Sci Adv. 2024;10(10):eadk9485.","DOI":"10.1126\/sciadv.adk9485"},{"key":"1827_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35579-6","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, et al. Chemical reaction-mediated covalent localization of bacteria. Nat Commun. 2022;13:7808.","journal-title":"Nat Commun"},{"key":"1827_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202007379","author":"C Pan","year":"2021","unstructured":"Pan C, et al. Polymerization-mediated multifunctionalization of living cells for enhanced cell\u2010based therapy. Adv Mater. 2021. https:\/\/doi.org\/10.1002\/adma.202007379.","journal-title":"Adv Mater"},{"key":"1827_CR87","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1021\/acs.accounts.3c00798","volume":"57","author":"L Wang","year":"2024","unstructured":"Wang L, Liu J. Dopamine polymerization-mediated surface functionalization toward advanced bacterial therapeutics. Acc Chem Res. 2024;57:945\u201356.","journal-title":"Acc Chem Res"},{"key":"1827_CR88","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202202409","author":"J Li","year":"2022","unstructured":"Li J, et al. Decorating bacteria with triple immune nanoactivators generates tumor-resident living immunotherapeutics. Angew Chem Int Ed Engl. 2022. https:\/\/doi.org\/10.1002\/anie.202202409.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1827_CR89","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202410113","volume":"34","author":"S Xiao","year":"2024","unstructured":"Xiao S, et al. Bacteria-mediated bismuth-based nanoparticles activate toll-like receptors for breast cancer photothermal immunotherapy. Adv Funct Mater. 2024;34:2410113.","journal-title":"Adv Funct Mater"},{"key":"1827_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20220010","author":"HR Jia","year":"2022","unstructured":"Jia HR, et al. Direct chemical editing of Gram-positive bacterial cell walls via an enzyme\u2010catalyzed oxidative coupling reaction. Exploration (Beijing, China). 2022. https:\/\/doi.org\/10.1002\/EXP.20220010.","journal-title":"Exploration (Beijing, China)"},{"key":"1827_CR91","doi-asserted-by":"publisher","first-page":"8421","DOI":"10.1002\/anie.201004340","volume":"49","author":"RM Hagan","year":"2010","unstructured":"Hagan RM, et al. NMR spectroscopic and theoretical analysis of a spontaneously formed lys\u2013asp isopeptide bond. Angew Chem Int Ed Engl. 2010;49:8421\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1827_CR92","doi-asserted-by":"publisher","first-page":"47428","DOI":"10.1074\/jbc.M209133200","volume":"277","author":"Y Terao","year":"2002","unstructured":"Terao Y, Kawabata S, Nakata M, Nakagawa I, Hamada S. Molecular characterization of a novel fibronectin-binding protein of Streptococcus pyogenes strains isolated from toxic shock-like syndrome patients. J Biol Chem. 2002;277:47428\u201335.","journal-title":"J Biol Chem"},{"key":"1827_CR93","doi-asserted-by":"publisher","first-page":"E690","DOI":"10.1073\/pnas.1115485109","volume":"109","author":"B Zakeri","year":"2012","unstructured":"Zakeri B, et al. Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin. Proc Natl Acad Sci U S A. 2012;109:E690\u2013697.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1827_CR94","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.cbpa.2015.10.002","volume":"29","author":"SC Reddington","year":"2015","unstructured":"Reddington SC, Howarth M. Secrets of a covalent interaction for biomaterials and biotechnology: SpyTag and SpyCatcher. Curr Opin Chem Biol. 2015;29:94\u20139.","journal-title":"Curr Opin Chem Biol"},{"key":"1827_CR95","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/fbe2.70023","volume":"4","author":"M-m Cai","year":"2025","unstructured":"Cai M-m, et al. Research progress based on SpyTag\/SpyCatcher self-assembling peptides and their applications in the food field. Food Bioeng. 2025;4:279\u201391.","journal-title":"Food Bioeng"},{"key":"1827_CR96","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.tibtech.2013.01.012","volume":"31","author":"S Gautam","year":"2013","unstructured":"Gautam S, Gniadek TJ, Kim T, Spiegel DA. Exterior design: strategies for redecorating the bacterial surface with small molecules. Trends Biotechnol. 2013;31:258\u201367.","journal-title":"Trends Biotechnol"},{"key":"1827_CR97","doi-asserted-by":"crossref","unstructured":"Moreno VM et al. Bacteria as Nanoparticles Carrier for Enhancing Penetration in a Tumoral Matrix Model. Adv Mater Interfaces. 2020 ;7(11):1901942.","DOI":"10.1002\/admi.201901942"},{"key":"1827_CR98","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01973-3","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, et al. Aptamer-drug conjugates-loaded bacteria for pancreatic cancer synergistic therapy. Signal Transduct Target Ther. 2024. https:\/\/doi.org\/10.1038\/s41392-024-01973-3.","journal-title":"Signal Transduct Target Ther"},{"key":"1827_CR99","doi-asserted-by":"crossref","unstructured":"Shi L et al. Living Bacteria-Based Immuno\u2010Photodynamic Therapy: Metabolic Labeling of Clostridium butyricum for Eradicating Malignant Melanoma. Adv Sci. 2022;9(14):e2105807.","DOI":"10.1002\/advs.202105807"},{"key":"1827_CR100","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41557-020-00587-w","volume":"12","author":"H Wang","year":"2020","unstructured":"Wang H, Mooney DJ. Metabolic glycan labelling for cancer-targeted therapy. Nat Chem. 2020;12:1102\u201314.","journal-title":"Nat Chem"},{"key":"1827_CR101","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1073\/pnas.0911116107","volume":"107","author":"PV Chang","year":"2010","unstructured":"Chang PV, et al. Copper-free click chemistry in living animals. Proc Natl Acad Sci. 2010;107:1821\u20136.","journal-title":"Proc Natl Acad Sci"},{"key":"1827_CR102","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1021\/acscentsci.2c00533","volume":"8","author":"W-F Song","year":"2022","unstructured":"Song W-F, et al. In Situ Bioorthogonal Conjugation of Delivered Bacteria with Gut Inhabitants for Enhancing Probiotics Colonization. ACS Cent Sci. 2022;8:1306\u201317.","journal-title":"ACS Cent Sci"},{"key":"1827_CR103","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1146\/annurev-biochem-061809-112742","volume":"81","author":"AL Lovering","year":"2012","unstructured":"Lovering AL, Safadi SS, Strynadka NCJ. Structural perspective of peptidoglycan biosynthesis and assembly. Annu Rev Biochem. 2012;81:451\u201378.","journal-title":"Annu Rev Biochem"},{"key":"1827_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202319400","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, et al. Development and applications of D-amino acid derivatives\u2010based metabolic labeling of bacterial peptidoglycan. Angew Chem Int Ed Engl. 2024. https:\/\/doi.org\/10.1002\/anie.202319400.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1827_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122970","volume":"315","author":"H Ji","year":"2025","unstructured":"Ji H, et al. Remolding probiotics for effective treatment of type 2 diabetes via oral administration. Biomaterials. 2025;315:122970.","journal-title":"Biomaterials"},{"key":"1827_CR106","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1073\/pnas.0812432106","volume":"106","author":"W Yi","year":"2009","unstructured":"Yi W, et al. Remodeling bacterial polysaccharides by metabolic pathway engineering. Proc Natl Acad Sci U S A. 2009;106:4207\u201312.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1827_CR107","doi-asserted-by":"publisher","first-page":"34997","DOI":"10.1021\/acsomega.2c03711","volume":"7","author":"F Sa\u00efdi","year":"2022","unstructured":"Sa\u00efdi F, et al. Evaluation of Azido 3-Deoxy-d-manno-oct-2-ulosonic Acid (Kdo) Analogues for Click Chemistry-Mediated Metabolic Labeling of Myxococcus xanthus DZ2 Lipopolysaccharide. ACS Omega. 2022;7:34997\u20135013.","journal-title":"ACS Omega"},{"key":"1827_CR108","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.chembiol.2023.03.004","volume":"30","author":"RM Bednar","year":"2023","unstructured":"Bednar RM, Karplus PA, Mehl RA. Site-specific dual encoding and labeling of proteins via genetic code expansion. Cell Chem Biology. 2023;30:343\u201361.","journal-title":"Cell Chem Biology"},{"key":"1827_CR109","doi-asserted-by":"publisher","first-page":"6735","DOI":"10.1021\/bi0300231","volume":"42","author":"Z Zhang","year":"2003","unstructured":"Zhang Z, et al. A New Strategy for the Site-Specific Modification of Proteins in Vivo. Biochemistry. 2003;42:6735\u201346.","journal-title":"Biochemistry"},{"key":"1827_CR110","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1016\/j.apsb.2022.05.006","volume":"12","author":"L Wu","year":"2022","unstructured":"Wu L, et al. Macrophage-mediated tumor-targeted delivery of engineered Salmonella typhi murium VNP20009 in anti-PD1 therapy against melanoma. Acta Pharm Sin B. 2022;12:3952\u201371.","journal-title":"Acta Pharm Sin B"},{"key":"1827_CR111","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01703-1","volume":"9","author":"L Wu","year":"2024","unstructured":"Wu L, et al. Camouflaging attenuated Salmonella by cryo-shocked macrophages for tumor-targeted therapy. Signal Transduct Target Ther. 2024;9:14.","journal-title":"Signal Transduct Target Ther"},{"key":"1827_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116918","volume":"45","author":"L Wu","year":"2026","unstructured":"Wu L, et al. Controlled pyroptosis of engineered macrophages enables biphasic antitumor via the release of oncolytic bacteria and inflammatory signals. Cell Rep. 2026;45:116918.","journal-title":"Cell Rep"},{"key":"1827_CR113","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11899-023-00687-7","volume":"18","author":"KL Chohan","year":"2023","unstructured":"Chohan KL, Siegler EL, Kenderian SS. CAR-T Cell Therapy: the Efficacy and Toxicity Balance. Curr Hematol Malig Rep. 2023;18:9\u201318.","journal-title":"Curr Hematol Malig Rep"},{"key":"1827_CR114","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","volume":"22","author":"KM Maalej","year":"2023","unstructured":"Maalej KM, et al. CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances. Mol Cancer. 2023;22:20.","journal-title":"Mol Cancer"},{"key":"1827_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202305384","volume":"36","author":"J-X An","year":"2024","unstructured":"An J-X, et al. Bacteria-based backpacks to enhance adoptive macrophage transfer against solid tumors. Adv Mater. 2024;36:2305384.","journal-title":"Adv Mater"},{"key":"1827_CR116","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb1952","author":"X Wang","year":"2020","unstructured":"Wang X, et al. Bioinspired oral delivery of gut microbiota by self-coating with biofilms. Sci Adv. 2020. https:\/\/doi.org\/10.1126\/sciadv.abb1952.","journal-title":"Sci Adv"},{"key":"1827_CR117","doi-asserted-by":"publisher","first-page":"114443","DOI":"10.1016\/j.addr.2022.114443","volume":"188","author":"F Wu","year":"2022","unstructured":"Wu F, Liu J. Decorated bacteria and the application in drug delivery. Adv Drug Deliv Rev. 2022;188:114443.","journal-title":"Adv Drug Deliv Rev"},{"key":"1827_CR118","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.snb.2015.09.034","volume":"224","author":"VD Nguyen","year":"2016","unstructured":"Nguyen VD, et al. Active tumor-therapeutic liposomal bacteriobot combining a drug (paclitaxel)-encapsulated liposome with targeting bacteria (Salmonella Typhimurium). Sens Actuators B Chem. 2016;224:217\u201324.","journal-title":"Sens Actuators B Chem"},{"key":"1827_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801309","volume":"6","author":"S Suh","year":"2019","unstructured":"Suh S, et al. Nanoscale bacteria-enabled autonomous drug delivery system (NanoBEADS) enhances intratumoral transport of nanomedicine. Adv Sci. 2019;6:1801309.","journal-title":"Adv Sci"},{"key":"1827_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202310735","volume":"36","author":"K Liu","year":"2024","unstructured":"Liu K, et al. Drug-loaded Bacillus Calmette\u2013Gu\u00e9rin bacteria for immuno-chemo combo therapy in bladder cancer. Adv Mater. 2024;36:2310735.","journal-title":"Adv Mater"},{"key":"1827_CR121","volume":"13","author":"L-Y Wu","year":"2026","unstructured":"Wu L-Y, et al. Octopus-inspired engineered bacteria with a plug-and-play surface display system achieves enhanced tumor-specific colonization and antitumor immunity. Mil Med Res. 2026;13:100030.","journal-title":"Mil Med Res"},{"key":"1827_CR122","doi-asserted-by":"publisher","first-page":"7822","DOI":"10.1002\/anie.201703317","volume":"56","author":"X Bi","year":"2017","unstructured":"Bi X, et al. Enzymatic Engineering of Live Bacterial Cell Surfaces Using Butelase 1. Angew Chem Int Ed Engl. 2017;56:7822\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"key":"1827_CR123","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41551-017-0181-y","volume":"2","author":"CL Ho","year":"2018","unstructured":"Ho CL, et al. Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention. Nat Biomedical Eng. 2018;2:27\u201337.","journal-title":"Nat Biomedical Eng"},{"key":"1827_CR124","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13727-9","volume":"10","author":"Z Cao","year":"2019","unstructured":"Cao Z, Wang X, Pang Y, Cheng S, Liu J. Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment. Nat Commun. 2019;10:5783.","journal-title":"Nat Commun"},{"key":"1827_CR125","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.1039\/D0FO03235B","volume":"12","author":"J Xie","year":"2021","unstructured":"Xie J, et al. Impact of encapsulating a probiotic (Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infections. Food Funct. 2021;12:3180\u201390.","journal-title":"Food Funct"},{"key":"1827_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26956-8","volume":"12","author":"Z Geng","year":"2021","unstructured":"Geng Z, et al. Aptamer-assisted tumor localization of bacteria for enhanced biotherapy. Nat Commun. 2021;12:6584.","journal-title":"Nat Commun"},{"key":"1827_CR127","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.7150\/thno.16135","volume":"6","author":"S-H Park","year":"2016","unstructured":"Park S-H, et al. RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated\u2009<\u2009i>Salmonella-mediated Cancer Therapy. Theranostics. 2016;6:1672\u201382.","journal-title":"Theranostics"},{"key":"1827_CR128","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1021\/sb500252a","volume":"4","author":"C Pi\u00f1ero-Lambea","year":"2015","unstructured":"Pi\u00f1ero-Lambea C, et al. Programming controlled adhesion of E. coli to target surfaces, cells, and tumors with synthetic adhesins. ACS Synth Biol. 2015;4:463\u201373.","journal-title":"ACS Synth Biol"},{"key":"1827_CR129","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201801309","author":"S Suh","year":"2019","unstructured":"Suh S, et al. Nanoscale bacteria-enabled autonomous drug delivery system (NanoBEADS) enhances intratumoral transport of nanomedicine. Adv Sci. 2019. https:\/\/doi.org\/10.1002\/advs.201801309.","journal-title":"Adv Sci"},{"key":"1827_CR130","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.bbrc.2019.05.074","volume":"514","author":"Y Luo","year":"2019","unstructured":"Luo Y, et al. Nanoparticles conjugated with bacteria targeting tumors for precision imaging and therapy. Biochem Biophys Res Commun. 2019;514:1147\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"1827_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119226","author":"F Chen","year":"2019","unstructured":"Chen F, et al. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials. 2019. https:\/\/doi.org\/10.1016\/j.biomaterials.2019.119226.","journal-title":"Biomaterials"},{"key":"1827_CR132","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1002\/cbic.202000102","volume":"21","author":"S Gallus","year":"2020","unstructured":"Gallus S, et al. Surface display of complex enzymes by in situ SpyCatcher-SpyTag interaction. Chembiochem. 2020;21:2126\u201331.","journal-title":"Chembiochem"},{"key":"1827_CR133","doi-asserted-by":"crossref","unstructured":"Kajiwara K, Aoki W, Koike N, Ueda M. Development of a yeast cell surface display method using the SpyTag\/SpyCatcher system. Sci Rep. 2021;11(1):11059.","DOI":"10.1038\/s41598-021-90593-w"},{"key":"1827_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2025.09.013","author":"L Li","year":"2025","unstructured":"Li L, et al. Precision tumor immunotherapy via a dual-gated macrophage\u2013bacterial activation platform. Trends Biotechnol. 2025. https:\/\/doi.org\/10.1016\/j.tibtech.2025.09.013.","journal-title":"Trends Biotechnol"},{"key":"1827_CR135","doi-asserted-by":"publisher","first-page":"19396","DOI":"10.1021\/jacs.2c07287","volume":"144","author":"L Wu","year":"2022","unstructured":"Wu L, et al. Combined Cellular Thermometry Reveals That Salmonella typhimurium Warms Macrophages by Inducing a Pyroptosis-like Phenotype. J Am Chem Soc. 2022;144:19396\u2013409.","journal-title":"J Am Chem Soc"},{"key":"1827_CR136","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s44222-022-00006-4","volume":"1","author":"X Zhang","year":"2023","unstructured":"Zhang X, Chen G, Zhang H, Shang L, Zhao Y. Bioinspired oral delivery devices. Nat Rev Bioeng. 2023;1:208\u201325.","journal-title":"Nat Rev Bioeng"},{"key":"1827_CR137","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114252","volume":"387","author":"Y You","year":"2025","unstructured":"You Y, et al. Probiotic encapsulation strategies for controlled intestinal delivery and microbiome dysbiosis therapy. J Control Release. 2025;387:114252.","journal-title":"J Control Release"},{"key":"1827_CR138","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.actbio.2019.11.050","volume":"103","author":"D Chouhan","year":"2020","unstructured":"Chouhan D, Mandal BB. Silk biomaterials in wound healing and skin regeneration therapeutics: From bench to bedside. Acta Biomater. 2020;103:24\u201351.","journal-title":"Acta Biomater"},{"key":"1827_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202101810","volume":"17","author":"W Hou","year":"2021","unstructured":"Hou W, et al. Decorating bacteria with a therapeutic nanocoating for synergistically enhanced biotherapy. Small. 2021;17:2101810.","journal-title":"Small"},{"key":"1827_CR140","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202001705","volume":"16","author":"AM Vargason","year":"2020","unstructured":"Vargason AM, Santhosh S, Anselmo AC. Surface modifications for improved delivery and function of therapeutic bacteria. Small. 2020;16:2001705.","journal-title":"Small"},{"key":"1827_CR141","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abp8798","volume":"8","author":"J Liu","year":"2022","unstructured":"Liu J, et al. Mucoadhesive probiotic backpacks with ROS nanoscavengers enhance the bacteriotherapy for inflammatory bowel diseases. Sci Adv. 2022;8:eabp8798.","journal-title":"Sci Adv"},{"key":"1827_CR142","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41565-023-01346-x","volume":"18","author":"F Cao","year":"2023","unstructured":"Cao F, et al. Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis. Nat Nanotechnol. 2023;18:617\u201327.","journal-title":"Nat Nanotechnol"},{"key":"1827_CR143","doi-asserted-by":"publisher","first-page":"e1808278","DOI":"10.1002\/adma.201808278","volume":"31","author":"JX Fan","year":"2019","unstructured":"Fan JX, et al. Engineered Bacterial Bioreactor for Tumor Therapy via Fenton-Like Reaction with Localized H2 O2 Generation. Adv Mater. 2019;31:e1808278.","journal-title":"Adv Mater"},{"key":"1827_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48606-5","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse. Nat Commun. 2024;15:4241.","journal-title":"Nat Commun"},{"key":"1827_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-024-01224-4","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Reinforcement of the intestinal mucosal barrier via mucus-penetrating PEGylated bacteria. Nat Biomed Eng. 2024. https:\/\/doi.org\/10.1038\/s41551-024-01224-4.","journal-title":"Nat Biomed Eng"},{"key":"1827_CR146","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1021\/acs.nanolett.5b00570","volume":"15","author":"Q Hu","year":"2015","unstructured":"Hu Q, et al. Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy. Nano Lett. 2015;15:2732.","journal-title":"Nano Lett"},{"key":"1827_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119226","volume":"214","author":"F Chen","year":"2019","unstructured":"Chen F, et al. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials. 2019;214:119226.","journal-title":"Biomaterials"},{"key":"1827_CR148","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201910176","volume":"30","author":"L Liu","year":"2020","unstructured":"Liu L, et al. In situ photocatalyzed oxygen generation with photosynthetic bacteria to enable robust immunogenic photodynamic therapy in triple-negative breast cancer. Adv Funct Mater. 2020;30:1910176.","journal-title":"Adv Funct Mater"},{"key":"1827_CR149","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c08350","author":"P Pan","year":"2022","unstructured":"Pan P, Dong X, Chen Y, Zeng X, Zhang XZ. Engineered bacteria for enhanced radiotherapy against breast carcinoma. ACS Nano. 2022. https:\/\/doi.org\/10.1021\/acsnano.1c08350.","journal-title":"ACS Nano"},{"key":"1827_CR150","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jconrel.2017.10.041","volume":"268","author":"S Xie","year":"2017","unstructured":"Xie S, et al. Doxorubicin-conjugated Escherichia coli Nissle 1917 swimmers to achieve tumor targeting and responsive drug release. J Control Release. 2017;268:390\u20139.","journal-title":"J Control Release"},{"key":"1827_CR151","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.actbio.2018.07.041","volume":"78","author":"S Xie","year":"2018","unstructured":"Xie S, et al. Bacterial microbots for acid-labile release of hybrid micelles to promote the synergistic antitumor efficacy. Acta Biomater. 2018;78:198\u2013210.","journal-title":"Acta Biomater"},{"key":"1827_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202106669","volume":"34","author":"L Wang","year":"2022","unstructured":"Wang L, Cao Z, Zhang M, Lin S, Liu J. Spatiotemporally controllable distribution of combination therapeutics in solid tumors by dually modified bacteria. Adv Mater. 2022;34:2106669.","journal-title":"Adv Mater"},{"key":"1827_CR153","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1021\/acs.nanolett.0c03811","volume":"21","author":"Z Mi","year":"2021","unstructured":"Mi Z, et al. \u201cTrojan horse\u201d Salmonella enabling tumor homing of silver nanoparticles via neutrophil infiltration for synergistic tumor therapy and enhanced biosafety. Nano Lett. 2021;21:414\u201323.","journal-title":"Nano Lett"},{"key":"1827_CR154","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.add7034","volume":"382","author":"RL Vincent","year":"2023","unstructured":"Vincent RL, et al. Probiotic-guided CAR-T cells for solid tumor targeting. Science. 2023;382:211\u20138.","journal-title":"Science"},{"key":"1827_CR155","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1086\/649557","volume":"201","author":"HS Warren","year":"2010","unstructured":"Warren HS, et al. Resilience to bacterial infection: difference between species could be due to proteins in serum. J Infect Dis. 2010;201:223\u201332.","journal-title":"J Infect Dis"},{"key":"1827_CR156","first-page":"60","volume":"12","author":"S Copeland","year":"2005","unstructured":"Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol. 2005;12:60\u20137.","journal-title":"Clin Diagn Lab Immunol"},{"key":"1827_CR157","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ymthe.2025.01.029","volume":"33","author":"A Senevirathne","year":"2025","unstructured":"Senevirathne A, Lloren KKS, Aganja RP, Kwon J, Lee JH. Transforming bacterial pathogens into wonder tools in cancer immunotherapy. Mol Ther. 2025;33:866\u201382.","journal-title":"Mol Ther"},{"key":"1827_CR158","doi-asserted-by":"publisher","first-page":"114363","DOI":"10.1016\/j.addr.2022.114363","volume":"187","author":"L Wu","year":"2022","unstructured":"Wu L, Bao F, Li L, Yin X, Hua Z. Bacterially mediated drug delivery and therapeutics: Strategies and advancements. Adv Drug Deliv Rev. 2022;187:114363.","journal-title":"Adv Drug Deliv Rev"},{"key":"1827_CR159","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202313953","volume":"36","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Synergistic brilliance: engineered bacteria and nanomedicine unite in cancer therapy. Adv Mater. 2024;36:2313953.","journal-title":"Adv Mater"},{"key":"1827_CR160","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/s43018-025-00932-3","volume":"6","author":"L Qiao","year":"2025","unstructured":"Qiao L, et al. Engineered bacteria for near-infrared light-inducible expression of cancer therapeutics. Nat Cancer. 2025;6:612\u201328.","journal-title":"Nat Cancer"},{"key":"1827_CR161","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/s41587-022-01244-y","volume":"40","author":"T Harimoto","year":"2022","unstructured":"Harimoto T, et al. A programmable encapsulation system improves delivery of therapeutic bacteria in mice. Nat Biotechnol. 2022;40:1259\u201369.","journal-title":"Nat Biotechnol"},{"key":"1827_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202406486","volume":"12","author":"ZP Zou","year":"2025","unstructured":"Zou ZP, et al. Self-adjusting engineered probiotic for targeted tumor colonization and local therapeutics delivery. Adv Sci. 2025;12:e06486.","journal-title":"Adv Sci"},{"key":"1827_CR163","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1111\/jam.15720","volume":"133","author":"L Wu","year":"2022","unstructured":"Wu L, et al. A SARS-CoV-2 oral vaccine development strategy based on the attenuated Salmonella type III secretion system. J Appl Microbiol. 2022;133:2484\u2013500.","journal-title":"J Appl Microbiol"},{"key":"1827_CR164","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/nchembio.1979","volume":"12","author":"CTY Chan","year":"2016","unstructured":"Chan CTY, Lee JW, Cameron DE, Bashor CJ, Collins JJ. \u201cDeadman\u201d and \u201cpasscode\u201d microbial kill switches for bacterial containment. Nat Chem Biol. 2016;12:82\u20136.","journal-title":"Nat Chem Biol"},{"key":"1827_CR165","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nature18930","volume":"536","author":"MO Din","year":"2016","unstructured":"Din MO, et al. Synchronized cycles of bacterial lysis for in vivo delivery. Nature. 2016;536:81\u20135.","journal-title":"Nature"},{"key":"1827_CR166","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1038\/s41467-024-45893-w","volume":"15","author":"N Hayashi","year":"2024","unstructured":"Hayashi N, Lai Y, Fuerte-Stone J, Mimee M, Lu TK. Cas9-assisted biological containment of a genetically engineered human commensal bacterium and genetic elements. Nat Commun. 2024;15:2096.","journal-title":"Nat Commun"},{"key":"1827_CR167","doi-asserted-by":"publisher","first-page":"38180","DOI":"10.1021\/jacs.5c10242","volume":"147","author":"S Qin","year":"2025","unstructured":"Qin S, et al. Metabolic Hijacking by Engineered Probiotics Reprograms Tumor Metabolism and Immune Microenvironment for Self-Reinforcing Photodynamic Immunotherapy. J Am Chem Soc. 2025;147:38180\u201394.","journal-title":"J Am Chem Soc"},{"key":"1827_CR168","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70059","volume":"6","author":"J Li","year":"2025","unstructured":"Li J, Liu Y, Gu A, Li MY. Patient-derived xenograft model in cancer: establishment and applications. MedComm. 2025;6:e70059.","journal-title":"MedComm"},{"key":"1827_CR169","doi-asserted-by":"publisher","DOI":"10.1177\/09636897261433327","volume":"35","author":"S Wang","year":"2026","unstructured":"Wang S, et al. New advances in the use of patient-derived organoids and mouse models for assessing heterogeneity among metastatic colorectal cancers. Cell Transplant. 2026;35:9636897261433327.","journal-title":"Cell Transplant"},{"key":"1827_CR170","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.addr.2012.09.008","volume":"64","author":"R Gref","year":"2012","unstructured":"Gref R, et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv Drug Deliv Rev. 2012;64:316\u201326.","journal-title":"Adv Drug Deliv Rev"},{"key":"1827_CR171","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s12951-024-02930-6","volume":"22","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Intestinal nanoparticle delivery and cellular response: a review of the bidirectional nanoparticle-cell interplay in mucosa based on physiochemical properties. J Nanobiotechnol. 2024;22:669.","journal-title":"J Nanobiotechnol"},{"key":"1827_CR172","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5056\/jnm23036","volume":"30","author":"YH Chang","year":"2024","unstructured":"Chang YH, et al. Efficacy of Quadruple-coated Probiotics in Patients With Irritable Bowel Syndrome: A Randomized, Double-blind, Placebo-controlled, Parallel-group Study. J Neurogastroenterol Motil. 2024;30:73\u201386.","journal-title":"J Neurogastroenterol Motil"},{"key":"1827_CR173","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202002406","author":"P Feng","year":"2020","unstructured":"Feng P, Cao Z, Wang X, Li J, Liu J. On-demand bacterial reactivation by restraining within a triggerable nanocoating. Adv Mater. 2020. https:\/\/doi.org\/10.1002\/adma.202002406.","journal-title":"Adv Mater"},{"key":"1827_CR174","doi-asserted-by":"crossref","unstructured":"Luo H et al. Chemical reaction-mediated covalent localization of bacteria. Nat Commun. 2022;13(1):7808.","DOI":"10.1038\/s41467-022-35579-6"},{"key":"1827_CR175","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202417050","author":"J Jiang","year":"2025","unstructured":"Jiang J, et al. Synergistic genetic and chemical engineering of probiotics for enhanced intestinal microbiota regulation and ulcerative colitis treatment. Adv Mater. 2025. https:\/\/doi.org\/10.1002\/adma.202417050.","journal-title":"Adv Mater"},{"key":"1827_CR176","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1021\/acs.nanolett.4c01143","volume":"24","author":"T Chen","year":"2024","unstructured":"Chen T, et al. Probiotics Armed with In Situ Mineralized Nanocatalysts and Targeted Biocoatings for Multipronged Treatment of Inflammatory Bowel Disease. Nano Lett. 2024;24:7321\u201331.","journal-title":"Nano Lett"},{"key":"1827_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202210949","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Dressing bacteria with a hybrid immunoactive nanosurface to elicit dual anticancer and antiviral immunity. Adv Mater. 2023. https:\/\/doi.org\/10.1002\/adma.202210949.","journal-title":"Adv Mater"},{"key":"1827_CR178","doi-asserted-by":"publisher","first-page":"10362","DOI":"10.1021\/acs.nanolett.4c03049","volume":"24","author":"Q-W Chen","year":"2024","unstructured":"Chen Q-W, Zhang Y, Bao P, Zhang X-Z. Sialidase-Chimeric Bioengineered Bacteria for Tumor-Sialoglycan-Triggered Solid Tumor Therapy. Nano Lett. 2024;24:10362\u201371.","journal-title":"Nano Lett"},{"key":"1827_CR179","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201909806","author":"Q-W Chen","year":"2020","unstructured":"Chen Q-W, et al. Self-mineralized photothermal bacteria hybridizing with mitochondria-targeted metal-organic frameworks for augmenting photothermal tumor therapy. Adv Funct Mater. 2020. https:\/\/doi.org\/10.1002\/adfm.201909806.","journal-title":"Adv Funct Mater"},{"key":"1827_CR180","doi-asserted-by":"publisher","first-page":"6118","DOI":"10.1021\/acsnano.1c11601","volume":"16","author":"H Chen","year":"2022","unstructured":"Chen H, et al. An engineered bacteria-hybrid microrobot with the magnetothermal bioswitch for remotely collective perception and imaging-guided cancer treatment. ACS Nano. 2022;16:6118\u201333.","journal-title":"ACS Nano"},{"key":"1827_CR181","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk9485","author":"M Chen","year":"2024","unstructured":"Chen M, et al. Upconversion dual-photosensitizer-expressing bacteria for near-infrared monochromatically excitable synergistic phototherapy. Sci Adv. 2024. https:\/\/doi.org\/10.1126\/sciadv.adk9485.","journal-title":"Sci Adv"},{"key":"1827_CR182","first-page":"19905","volume":"18","author":"H Guo","year":"2024","unstructured":"Guo H, et al. Integrating Bacteria with a Ternary Combination of Photosensitizers for Monochromatic Irradiation-Mediated Photoacoustic Imaging-Guided Synergistic Photothermal Therapy (17, pg 5059, 2023). ACS Nano. 2024;18:19905\u201319905.","journal-title":"ACS Nano"},{"key":"1827_CR183","doi-asserted-by":"publisher","first-page":"8735","DOI":"10.1021\/acs.nanolett.2c03608","volume":"22","author":"J-W Wang","year":"2022","unstructured":"Wang J-W, et al. Interference of glucose bioavailability of tumor by engineered biohybrids for potentiating targeting and uptake of antitumor nanodrugs. Nano Lett. 2022;22:8735\u201343.","journal-title":"Nano Lett"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01827-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01827-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:50:34Z","timestamp":1788324634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01827-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01827-1","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors read and approved the final manuscript for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"74"}}